menu
    • menu

    Company profile for Bone Biologics

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development. Currently finalizing pivotal animal studies Clearance to move into human studies in Australia Potential commercialization into $3 billion dollar orthobiol...
    Bone Biologics is a publicly traded company based in Burlington, MA and is focused on developing and marketing orthobiologic products. Our proprietary platform technology is NELL-1, a recombinant human protein growth factor that is essential for normal bone development. Currently finalizing pivotal animal studies Clearance to move into human studies in Australia Potential commercialization into $3 billion dollar orthobiologics market pending successful completion of pivotal human studies in U.S

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bone BiologicsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Burlington Woods Drive, Suite 100 Burlington, MA 01803
    Telephone
    Telephone
    781-552-4452
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bonebiologics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bone Biologics Showcases 2025 Achievements, Sets 2026 Goals
    Bone Biologics Showcases 2025 Achievements, Sets 2026 Goals

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215289/0/en/Bone-Biologics-Highlights-2025-Key-Operational-Scientific-and-Corporate-Milestones-and-Provides-2026-Outlook.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Bone Biologics Extends Rhnell-1 Product Shelf Life To 24 Months
    Bone Biologics Extends Rhnell-1 Product Shelf Life To 24 Months

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3209834/0/en/Bone-Biologics-Improves-Extension-of-rhNELL-1-Product-Shelf-Life-to-24-Months.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Bone Biologics CEO Shares Update and Outlook With Stockholders
    Bone Biologics CEO Shares Update and Outlook With Stockholders

    04 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250904789999/en/Bone-Biologics-CEO-Issues-Letter-to-Stockholders-Highlighting-Company-Update-and-Outlook

    BUSINESSWIRE
    04 Sep 2025
    Share Share
    Bone Bio to Participate in H.C. Wainwright Investment Conference
    Bone Bio to Participate in H.C. Wainwright Investment Conference

    03 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250903959890/en/Bone-Biologics-to-Participate-in-the-H.C.-Wainwright-Global-Investment-Conference

    BUSINESSWIRE
    03 Sep 2025
    Share Share
    Bone Biologics Patents Bone Regeneration Technology
    Bone Biologics Patents Bone Regeneration Technology

    27 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250627795812/en/Bone-Biologics-Files-Patent-Application-for-Bone-Regeneration-Technology

    BUSINESSWIRE
    27 Jun 2025
    Share Share
    Bone Biologics Regains Nasdaq Listing Compliance
    Bone Biologics Regains Nasdaq Listing Compliance

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250626668160/en/Bone-Biologics-Regains-Compliance-with-Nasdaq-Continued-Listing-Requirements

    BUSINESSWIRE
    26 Jun 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search